The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats
about
The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting gliaMechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapyMechanisms of chemotherapy-induced behavioral toxicitiesAstrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the ratPaclitaxel-induced increase in mitochondrial volume mediates dysregulation of intracellular Ca2+ in putative nociceptive glabrous skin neurons from the ratEnhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathyNorth Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled studyGlobal inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy.Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic ratsFurther data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-α expression in a mouse model.Prevention of paclitaxel-induced allodynia by minocycline: Effect on loss of peripheral nerve fibers and infiltration of macrophages in rats.Paclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline.Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocyclineProtection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients.Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathyDifferential Effectiveness of Clinically-Relevant Analgesics in a Rat Model of Chemotherapy-Induced Mucositis.Rikkunshito prevents paclitaxel-induced peripheral neuropathy through the suppression of the nuclear factor kappa B (NFκB) phosphorylation in spinal cord of mice.Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivityDorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral NeuropathyMinocycline attenuates bone cancer pain in rats by inhibiting NF-κB in spinal astrocytes.Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic painPlasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligationInduction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathyAnti-nociceptive effect of a conjugate of substance P and light chain of botulinum neurotoxin type AInhibition of glycogen synthase kinase 3β activity with lithium prevents and attenuates paclitaxel-induced neuropathic pain.Glycogen synthase kinase 3 beta regulates glial glutamate transporter protein expression in the spinal dorsal horn in rats with neuropathic pain.Effects of Taxol on Regeneration in a Rat Sciatic Nerve Transection ModelChemotherapy-related cognitive dysfunction: current animal studies and future directions.Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain.Anti-nociceptive roles of the glia-specific metabolic inhibitor fluorocitrate in paclitaxel-evoked neuropathic pain.A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.P2 receptors, microglial cytokines and chemokines, and neuropathic pain.Neuroimmune mechanisms of behavioral alterations in a syngeneic murine model of human papilloma virus-related head and neck cancer.Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture.Regulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy.The possible involvement of JNK activation in the spinal dorsal horn in bortezomib-induced allodynia: the role of TNF-α and IL-1β.
P2860
Q24650739-A9ED5276-C355-4F1D-87F4-8D963A1A3A2EQ26751146-E61EE59A-A14E-4128-BDE3-D747FEA25675Q26998870-68A55E90-9D62-4395-ADE2-8DB0911280C6Q28390312-AFFEEBAB-9C56-4B13-A37E-D26A7F13A853Q29248252-0EBE6E99-28B8-4E1D-A5AC-154FF03A98F4Q33650951-C38E3FE3-B34D-4A85-8DE8-95A7B878DBF5Q33717608-48B2F779-31A6-4E55-A12C-EBD482FEBA2BQ34038073-FD3F0428-61FB-40D5-9B24-547D0671B3DFQ34126485-0D01B0B7-323C-447C-95D2-FC939FE03009Q34194773-D56F713E-22C4-4A14-9A2E-E4734DE666B3Q34221568-11F35151-262C-416C-B9FB-1AF14C7F9648Q34347705-46C2D7A0-ADF3-4147-873A-F75F04F52C3AQ34384978-54B9B115-784D-4281-8228-B732F727B5FFQ34496656-CD37A652-A037-4CAB-8E0E-7F60D469AEC7Q35000576-1074695A-9863-484A-90E5-5E570A4D9094Q35188312-3D88C06C-8D45-4A3B-8B2E-9BBB30220146Q35803293-EDD36B6D-21AA-47FE-8C9E-2E310921B871Q36087227-2274B6B3-FB1F-4182-8B08-54A5FDFDB908Q36275592-7A1F3E59-E5CD-43D9-B2E9-AA4264E9B834Q36439933-C0E6EF86-0A55-4ADF-8FC9-AB104B59F308Q36586687-450B70E1-A93A-46D5-AAAC-48E95144F577Q37081502-85131A69-C256-4527-85A7-833CB058B26FQ37112300-13C1762A-6C7D-4D16-991D-CF2B15CB3F2CQ37117256-81445315-F9E7-4534-8AF1-DE73D56FB48DQ37177060-4C83B81D-6FA7-4270-B007-92575E3C2FECQ37216797-FDCFBE31-0122-4E01-B190-BA859322DF50Q37255758-5DAC39F3-9226-4DA2-8D61-0704EA756DFBQ37317816-A6A3EF07-C9A5-40AE-B8DF-D508F8AFD0BEQ37625466-B2E622D3-EAEE-416A-B6D4-D11307497BC5Q37633265-B5767255-CE0B-48CE-93E8-DB0411156221Q38129330-2AFDC7B7-713A-4754-8AB7-E960FA60653BQ38264622-89C966D8-45F5-4BA2-8A49-62C7FF4F3839Q38697158-AC66DC21-DB2F-4BAB-8632-B62747434B33Q38750007-EE9B3D1D-A88F-4E0A-8ACA-B30CE96EFEF1Q38759777-E6C0CD97-E04B-42CD-97B2-1ED0484A7D59Q38885571-4B557FED-E798-448D-9080-F9AC6A54E557Q38929870-6AFFDEC2-C6EF-4B1C-A0B3-2046A04A0C98Q39283600-E5E45D20-C24E-42BE-B4F9-B95B6E8A7569Q40124861-CB040A6F-E604-4398-9C0E-8F113F180002Q40536105-9F56951E-7E7A-4355-899C-1D9351B11D5B
P2860
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats
@en
type
label
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats
@en
prefLabel
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats
@en
P2860
P1433
P1476
The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats
@en
P2093
Han-Rong Weng
Juan P Cata
P2860
P304
P356
10.1016/J.BRAINRES.2008.07.001
P407
P577
2008-07-09T00:00:00Z